NDC 0002-2236 – Trulicity

Dulaglutide 3 mg/.5mL · Injection, Solution · Subcutaneous

Human Prescription Drug 2 recalls

Product NDC0002-2236

Product details

Brand name
Trulicity
Generic name
Dulaglutide
Labeler
Eli Lilly and Company
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA125469
Marketed since
September 3, 2020
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Trulicity →

Package NDC codes (1)

Package NDCDescriptionSince
0002-2236-804 SYRINGE in 1 CARTON (0002-2236-80) / .5 mL in 1 SYRINGE (0002-2236-01)Sep 3, 2020

Recalls mentioning this NDC

Other Trulicity products